Clinical Trial Update: Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topical 0.5% ivermectin cream for demodicidosis and rosacea; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Demodicidosis
• Rosacea

Drugs mentioned

• Ivermectin topical cream (ivermectin)

Snippet

Sponsor: Rabin Medical Center | Conditions: Demodicidosis, Rosacea | Phase 3 | Status: UNKNOWN